Company logo

UNH - UnitedHealth Group Incorporated

NYSE -> Healthcare -> Healthcare Plans
Minnetonka, United States
Type: Equity

UNH price evolution
UNH
(in millions $) 31 Jan 2024 30 Oct 2023 30 Jul 2023 1 May 2023
Current assets
Cash $25427 $38915 $41813 $41913
Short term investments $7956 $8798 $8089 $8421
Net receivables $38970 $38425 $34083 $37110
Inventory
Total current assets $78437 $91905 $89869 $93895
Long term investments $47609 $45474 $45988 $46884
Property, plant & equipment $11450 $11070 $10926 $10637
Goodwill & intangible assets $118926 $116903 $117312 $116571
Total noncurrent assets $195283 $190158 $190295 $189784
Total investments $55565 $54272 $54077 $55305
Total assets $273720 $282063 $280164 $283679
Current liabilities
Accounts payable $64353 $63956 $61463 $61665
Deferred revenue $3355 $15311 $14852 $14487
Short long term debt $4274 $5290 $6321 $9931
Total current liabilities $4274 $5290 $6321 $9931
Long term debt $58263 $58079 $59268 $60657
Total noncurrent liabilities $75747 $73904 $75027 $76575
Total debt $62537 $63369 $65589 $70588
Total liabilities $179299 $192499 $192796 $197858
Shareholders' equity
Retained earnings $95774 $93173 $89994 $88852
Other shareholder equity $94421 $89564 $87368 $85821
Total shareholder equity $88756 $84494 $82353 $81312
(in millions $) 31 Jan 2024 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $25427 $23365 $21375 $16921
Short term investments $7956 $8633 $6981 $6936
Net receivables $38970 $12769 $28082 $25404
Inventory
Total current assets $78437 $19390 $61758 $53718
Long term investments $47609 $43728 $43114 $41242
Property, plant & equipment $11450 $10128 $8969 $8626
Goodwill & intangible assets $118926 $107753 $85839 $82193
Total noncurrent assets $195283 $176636 $150448 $143571
Total investments $55565 $52361 $50095 $48178
Total assets $273720 $245705 $212206 $197289
Current liabilities
Accounts payable $64353 $27715 $49126 $44367
Deferred revenue $3355 $3075 $2571 $2842
Short long term debt $4274 $3110 $3620 $4819
Total current liabilities $4274 $3110 $78292 $72420
Long term debt $58263 $54513 $42383 $38648
Total noncurrent liabilities $75747 $70121 $57435 $54330
Total debt $62537 $57623 $46003 $43467
Total liabilities $179299 $164255 $135727 $126750
Shareholders' equity
Retained earnings $95774 $86156 $77134 $69295
Other shareholder equity $94421 $81450 -$5384 -$3814
Total shareholder equity $88756 $77772 $71760 $65491
(in millions $) 31 Jan 2024 30 Oct 2023 30 Jul 2023 31 Mar 2023
Revenue
Total revenue $91931
Cost of revenue $69250
Gross Profit $22681
Operating activities
Research & development
Selling, general & administrative $13625
Total operating expenses $14595
Operating income $8086
Income from continuing operations
EBIT $7923
Income tax expense $1558
Interest expense $754
Net income
Net income $5611
Income (for common shares) $5611
(in millions $) 31 Jan 2024 31 Dec 2022 31 Jan 2022 31 Dec 2020
Revenue
Total revenue $371622 $324162 $257141
Cost of revenue $244545 $190141
Gross Profit $79617 $67000
Operating activities
Research & development
Selling, general & administrative $47782 $41704
Total operating expenses $339264 $51182 $44595
Operating income $28435 $22405
Income from continuing operations
EBIT $27916 $22039
Income tax expense $5968 $5704 $4973
Interest expense -$3246 $2092 $1663
Net income
Net income $22381 $20120 $15403
Income (for common shares) $20120 $15403
(in millions $) 31 Jan 2024 30 Oct 2023 30 Jul 2023 31 Mar 2023
Net income $5611
Operating activities
Depreciation $970
Business acquisitions & disposals -$7826
Stock-based compensation $362
Total cash flows from operations $16327
Investing activities
Capital expenditures -$760
Investments -$2319
Total cash flows from investing -$15574 -$14387 -$11748 -$11020
Financing activities
Dividends paid -$6761 -$5023 -$3284 -$1537
Sale and purchase of stock -$1656
Net borrowings $12375
Total cash flows from financing -$11529 -$4373 $2731 $13190
Effect of exchange rate $97 $49 $106 $51
Change in cash and equivalents $2062 $15550 $18448 $18548
(in millions $) 31 Jan 2024 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income $20120 $17285 $15403
Operating activities
Depreciation $3400 $3103 $2891
Business acquisitions & disposals -$18044 -$4821 -$7139
Stock-based compensation $925 $800 $679
Total cash flows from operations $26206 $22343 $22174
Investing activities
Capital expenditures -$2802 -$2454 -$2051
Investments -$6837 -$1843 -$2836
Total cash flows from investing -$15574 -$28476 -$10372 -$12532
Financing activities
Dividends paid -$6761 -$5991 -$5280 -$4584
Sale and purchase of stock -$5747 -$3645 -$2810
Net borrowings $12536 $2481 $2586
Total cash flows from financing -$11529 $4226 -$7455 -$3590
Effect of exchange rate $97 $34 -$62 -$116
Change in cash and equivalents $2062 $1990 $4454 $5936
Fundamentals
Market cap $456.08B
Enterprise value $493.19B
Shares outstanding 924.93M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio -80.51
Book/Share -6.12
Cash/Share 27.49
EPS N/A
ROA N/A
ROE N/A
Debt/Equity 2.02
Net debt/EBITDA N/A
Current ratio 18.35
Quick ratio 18.35